NMTC (NeuroOne Medical Technologies) Ending Cash Position: $2.05 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NMTC NeuroOne Medical Technologies Corp NMTC
21 GF Score
Price $1.97
! 4 Warning Signs
View Full Analysis

What is NeuroOne Medical Technologies Ending Cash Position?

NeuroOne Medical Technologies NMTC +5.15% 21 Ending Cash Position is $2.05 Mil as of Jun. 2026. GuruFocus rates NMTC with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

NeuroOne Medical Technologies's Ending Cash Position for the quarter that ended in Jun. 2026 was $2.05 Mil.

NeuroOne Medical Technologies's quarterly Ending Cash Position declined from Dec. 2025 ($3.56 Mil) to Mar. 2026 ($2.80 Mil) and declined from Mar. 2026 ($2.80 Mil) to Jun. 2026 ($2.05 Mil).

NeuroOne Medical Technologies's annual Ending Cash Position declined from Sep. 2023 ($5.32 Mil) to Sep. 2024 ($1.46 Mil) but then increased from Sep. 2024 ($1.46 Mil) to Sep. 2025 ($6.57 Mil).

NeuroOne Medical Technologies Ending Cash Position Related Terms

NeuroOne Medical Technologies Ending Cash Position Historical Data

* Premium members only.

The historical data trend for NeuroOne Medical Technologies's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeuroOne Medical Technologies Ending Cash Position Chart

NeuroOne Medical Technologies Annual Data
Trend Dec16 Dec17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.90 8.16 5.32 1.46 6.57

NeuroOne Medical Technologies Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.04 6.57 3.56 2.80 2.05
NMTC
21GF Score
NeuroOne Medical Technologies Corp NMTC
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeuroOne Medical Technologies Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

NeuroOne Medical Technologies's Ending Cash Position for the fiscal year that ended in Sep. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.46+5.11
=6.57

NeuroOne Medical Technologies's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=2.805+-0.757
=2.05

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $2.05 Mil mean?
NeuroOne Medical Technologies (NMTC) has a Ending Cash Position of $2.05 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on NeuroOne Medical Technologies and its competitors.
Is NeuroOne Medical Technologies' Ending Cash Position too high?
NeuroOne Medical Technologies' current Ending Cash Position is $2.05 Mil. Overall, NeuroOne Medical Technologies has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does NeuroOne Medical Technologies' Ending Cash Position compare to CSDX and IRIX?
NeuroOne Medical Technologies' Ending Cash Position of $2.05 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on NeuroOne Medical Technologies and its competitors. NeuroOne Medical Technologies's current Ending Cash Position is $2.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeuroOne Medical Technologies stock overvalued right now?
NeuroOne Medical Technologies (NMTC) has a current Ending Cash Position of $2.05 Mil. The current Ending Cash Position is $2.05 Mil. NeuroOne Medical Technologies' overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For NeuroOne Medical Technologies (NMTC), the current Ending Cash Position is $2.05 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NeuroOne Medical Technologies Business Description

Address 7599 Anagram Drive, Eden Prairie, MN, USA, 55344
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
21GF Score

Get the complete analysis for NMTC

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.97
Price